Blood tests to predict silent strokes after heart procedures
Part of Mental health clinical trials.
This study looks at whether certain blood tests can help predict if small, silent strokes occur in the brain during heart or blood vessel procedures that carry a higher risk of clots. The goal is to better identify who might need extra protection during these procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must agree to the study's monitoring schedule.
- You must not have an active diagnosis of cancer.
- You must be willing to give your informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often “silent” atrial fibrillation—an irregular heart rhythm that can be symptom-free—happens in people who have silent brain stroke spots on MRI. If it finds a link, it may help identify which patients might benefit from closer heart monitoring or prevention steps.
This study looks for what may have caused “silent” mini-strokes in the brain that were found on MRI, and which risk factors might be changeable. It may help doctors better understand how to prevent future stroke in people who have no clear stroke symptoms from the finding.
This study tests whether blood thinners and/or cholesterol-lowering medications can prevent future strokes in people who have small, silent brain infarctions found on MRI. If you've never had a stroke or TIA before, and are not already on similar medications, you may be a candidate.
This study is testing whether certain substances in your blood can help doctors better detect and understand problems with blood flow in the brain. Researchers hope these new 'biomarkers' could lead to faster and more accurate diagnosis of conditions like stroke and mini-stroke.
This study looks at whether blood tests taken after your first stroke can help predict if you might have memory or thinking problems early on. It focuses on people with a stroke in the basal ganglia area of the brain, with the goal of identifying those who may need extra support sooner.
This trial studies tiny particles in your blood (called extracellular vesicles) to understand and predict stroke risk after a TIA (a temporary stroke-like episode). It may help doctors identify who is at higher risk using blood samples, rather than only symptoms and scans.
Hear when a new Biomarkers / Blood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.